Advanced company searchLink opens in new window

INFEX THERAPEUTICS HOLDINGS PLC

Company number 13917179

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
08 Sep 2022 SH01 Statement of capital following an allotment of shares on 26 August 2022
  • GBP 68,926.07
02 Sep 2022 MA Memorandum and Articles of Association
02 Sep 2022 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
  • RES10 ‐ Resolution of allotment of securities
25 Jul 2022 AA01 Current accounting period extended from 31 July 2022 to 31 July 2023
14 Jun 2022 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES13 ‐ Appointment of director/ company business 09/06/2022
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
13 May 2022 TM01 Termination of appointment of Anthony Flinn as a director on 12 May 2022
10 May 2022 SH07 Cancellation of shares by a PLC. Statement of capital on 5 May 2022
  • GBP 54,926.07
05 May 2022 BS Balance Sheet
05 May 2022 AUDR Auditor's report
05 May 2022 AUDS Auditor's statement
05 May 2022 CERT5 Certificate of re-registration from Private to Public Limited Company
05 May 2022 MAR Re-registration of Memorandum and Articles
05 May 2022 RESOLUTIONS Resolutions
  • RES02 ‐ Resolution of re-registration
05 May 2022 RR01 Re-registration from a private company to a public company including appointment of secretary(s)
19 Apr 2022 MR01 Registration of charge 139171790001, created on 6 April 2022
11 Apr 2022 MA Memorandum and Articles of Association
11 Apr 2022 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
08 Apr 2022 AP01 Appointment of Mr Christopher Doherty as a director on 6 April 2022
07 Apr 2022 AP01 Appointment of Dr Anthony Flinn as a director on 6 April 2022
07 Apr 2022 AP01 Appointment of Mr Jonathan Paul Moulton as a director on 6 April 2022
07 Apr 2022 PSC07 Cessation of Peter Jackson as a person with significant control on 6 April 2022
07 Apr 2022 PSC02 Notification of Catapult Life Sciences Gp Llp as a person with significant control on 6 April 2022
07 Apr 2022 PSC01 Notification of Jonathan Paul Moulton as a person with significant control on 6 April 2022
07 Apr 2022 SH01 Statement of capital following an allotment of shares on 6 April 2022
  • GBP 54,926.071
05 Apr 2022 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association